Regardless of these dissimilarities, PERK abrogation through genetic maneuvers, significantly diminished (but not completely abolished) the immunogenicity of stressed cancer cells in vivo (Panaretakis et al., 2009; Garg et al., 2012c). This evidence concerns the gene EIF2AK3 and cancer.